EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Reducing brain kynurenic acid synthesis precludes kynurenine‐induced sleep disturbances

Katherine M Rentschler, Snezana Milosavljevic, Annalisa M Baratta, Courtney J Wright, Maria V Piroli, Zachary Tentor, Homayoun Valafar, Christian O'Reilly, Ana Pocivavsek iD

Journal of Sleep Research · 2024

DOI: 10.1111/jsr.14038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Sleep Research, 2024. Verfasst von Katherine M Rentschler und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of South Carolina School of Medicine, Department of Pharmacology, Physiology, and Neuroscience, Columbia, South Carolina, USA. Hauptthemen laut MEDLINE: Kynurenic Acid, Kynurenine, Rats, Wistar, Brain. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIMH NIH HHS, NINDS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with neurocognitive disorders often battle sleep disturbances. Kynurenic acid is a tryptophan metabolite of the kynurenine pathway implicated in the pathology of these illnesses. Modest increases in kynurenic acid, an antagonist at glutamatergic and cholinergic receptors, result in cognitive impairments and sleep dysfunction. We explored the hypothesis that inhibition of the kynurenic acid synthesising enzyme, kynurenine aminotransferase II, may alleviate sleep disturbances. At the start of the light phase, adult male and female Wistar rats received systemic injections of either: (i) vehicle; (ii) kynurenine (100 mg kg −1 ; i.p.); (iii) the kynurenine aminotransferase II inhibitor, PF‐04859989 (30 mg kg −1 ; s.c.); or (iv) PF‐04859989 and kynurenine in combination. Kynurenine and kynurenic acid levels were evaluated in the plasma and brain. Separate animals were implanted with electroencephalogram and electromyogram telemetry devices to record polysomnography, and evaluate the vigilance states wake, rapid eye movement sleep and non‐rapid eye movement sleep following each treatment. Kynurenine challenge increased brain kynurenic acid and resulted in reduced rapid eye movement sleep duration, non‐rapid eye movement sleep delta power and sleep spindles. PF‐04859989 reduced brain kynurenic acid formation when given prior to kynurenine, prevented disturbances in rapid eye movement sleep and sleep spindles, and enhanced non‐rapid eye movement sleep. Our findings suggest that reducing kynurenic acid in conditions where the kynurenine pathway is activated may serve as a potential strategy for improving sleep dynamics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kynurenic AcidKynurenineRats, WistarBrainAnimalsMaleFemaleRatsSleep Wake DisordersTransaminasesElectroencephalographyWakefulnessPolysomnographyElectromyography

Stichwörter der Autor:innen

neuropharmacologynon‐rapid eye movement sleeprapid eye movement sleepsleep spindlestryptophan⍺7 nicotinic acetylcholine receptor

Substanzen

Kynurenic AcidKynureninekynurenine-oxoglutarate transaminaseTransaminases

Autor:innen und Institutionen

  • University of South Carolina School of Medicine, Department of Pharmacology, Physiology, and Neuroscience, Columbia, South Carolina, USA.
  • Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Current affiliation: Center for Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Computer Science and Engineering, University of South Carolina, Columbia, South Carolina, USA.
  • Artificial Intelligence Institute, University of South Carolina, Columbia, South Carolina, USA.

ORCID-Profile: Ana Pocivavsek

Förderung

  • NIMH NIH HHS
  • NINDS NIH HHS
  • National Institutes of Health
  • National Science Foundation

Zitieren

APA

Rentschler, K. M., Milosavljevic, S., Baratta, A. M., Wright, C. J., Piroli, M. V., Tentor, Z., Valafar, H., O'Reilly, C., & Pocivavsek, A. (2024). Reducing brain kynurenic acid synthesis precludes kynurenine‐induced sleep disturbances. Journal of Sleep Research. https://doi.org/10.1111/jsr.14038

Vancouver

Rentschler KM, Milosavljevic S, Baratta AM, Wright CJ, Piroli MV, Tentor Z, et al. Reducing brain kynurenic acid synthesis precludes kynurenine‐induced sleep disturbances. Journal of Sleep Research. 2024. doi:10.1111/jsr.14038

BibTeX
@article{Rentschler2024,
  author = {Rentschler, Katherine M and Milosavljevic, Snezana and Baratta, Annalisa M and Wright, Courtney J and Piroli, Maria V and Tentor, Zachary and Valafar, Homayoun and O'Reilly, Christian and Pocivavsek, Ana},
  title = {Reducing brain kynurenic acid synthesis precludes kynurenine‐induced sleep disturbances},
  journal = {Journal of Sleep Research},
  year = {2024},
  doi = {10.1111/jsr.14038}
}
Kostenlos starten →